Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizPubPat, Consumer WatchDog get it wrong in Tafas brief
By Lawrence B. Ebert, Esq.
page 12-->it is impossible for an
examiner to ever actually finally reject a patent application so
long as the applicant has sufficient financial resources to keep
paying for continuation applications. Final Rules at 46718-19
(citing Mark A. Lemley & Kimberly A. Moore, Ending Abuse of
Patent Continuations, 84 B. U. L. Rev. 63 (2004)). This results in
USPTO examiners who have repeatedly rejected an application
facing the possibility of an endless stream of continuation
applications being filed by the applicant that ?may well succeed
in 'wearing down' the examiner, so that the applicant obtains a
(page 13)broad patent not because he deserves one, but because the
examiner has neither incentive nor will to hold out any longer.?
Lemley & Moore, 85 B. U. L. Rev. at 65. Such ?wearing down? of
examiners is an abhorrent abuse of continuation applications.
page 13-->Applicants also abuse the continuation application process
in other ways. Some monitor commercial actors who attempt to
design around a previously issued patent and then submit claims
in a much later filed continuation application that are directed
specifically at those design-around efforts. Id. at 76-77.
IPBiz notes that the most abundant form of continuing application is the
RCE, and one can't do this in an RCE.
Page 22-->A recent study showed that about one third of patent
applications are continuations. Lemley & Moore, 85 B. U. L. Rev.
at 69. This not only provides opportunities for the
gamesmanship discussed above, but it also results in a
significant amount of rework by patent examiners, which adds
substantial inefficiency into the patent application process.
IPBiz notes that this is an irresponsible citation for the year 2008. About
one third of applications are CONTINUING applications, the most abundant of
which is an RCE, which is NOT a continuation. Ravicher simply does not
understand what he is talking about in the brief.
Page 25-->First, continuation applications, as compared with original
applications, are more likely to result in patents that are
undeserved. Lemley & Moore, 85 B. U. L. Rev. at 75.
***See also
http://ipbiz.blogspot.com/2008/07/dominance-of-rces-and-lemleymoore.html
[Much of what Ravicher said in the amicus brief is negated by the article
published in 88 JPTOS 743 (2006)]
http://ipbiz.blogspot.com/2008/07/consumerwatchdog-and-pubpat-theyre-back.html#comments
which comment says:
Interestingly, Arti K. Rai, who wrote the Patently-O article as to why the district court judge was wrong to issue the preliminary injunction in the Tafas case, is on the Pubpat Board of Directors:
http://www.pubpat.org/Board.htm
And we thought she was just giving us a scholarly, unbiased, administrative perspective. :-)
http://www.patentlyo.com/patent/2007/11/the-gsk-case-an.html
And, as IPBiz noted elsewhere, Mark Lemley received financial support from Cisco (and others) for a recent
law review article. Can we say "conflict of interest"?
Full post as published by IPBiz on July 31, 2008 (boomark / email).
Truth In Lending Act
Consumer Loans and Consumer Credit Protection Act
Wrong Bus
Greenbrier County Board of Education agrees to $15,000 negligence settlement after dropping a 5-year-old off at the wrong spot.
Wrong Medication
Walgreens agrees to confidential settlement after woman suffers miscarriage.
CVS
Consumer Products Sold Past Their Expirey Dates
Mexican Vanilla Containing Coumarin
, FDA Issues Consumer Update
Ford Focus
Consumer Class Action Settles for Cash Refunds
AmeriGas, Blue Rhino
Face Consumer Class Action

Public Interest Groups Back USPTO in Tafas v. Dudas Appeal
Dr. Tafas Files Brief in New Rules Appeal
Tafas v. Dudas: USPTO Exceded Its Rulemaking Authority with Proposed Limitations on Continuations
Tafas v. Dudas: The Continuation Wars
No April Fool's Joke -- Tafas and GSK Win on Summary Judgment
Consumer Groups File CAFC Amicus Brief in Support of USPTO Rule Changes








